This webinar covers an introduction to PBPK and QSP modeling, including a brief explanation of each approach while also diving deeper into how they can be applied across all stages of drug development. The webinar will also touch upon the advantages of integrating these approaches early in your drug development pipeline.
At the end of this webinar, attendees should have a better understanding of:
- The core principles behind PBPK and QSP modeling
- How data collected through standard drug development can be better prioritized by incorporating these modeling tools early in the process
- Where PBPK and QSP modeling can be applied for drugs currently in various stages of the development pipeline
Meet the Presenter
Salil N. Pendse, M.S.
Quantitative Systems Pharmacologist II
Salil has more than 7 years of experience building mathematical models of cellular modes of action, physiologically-based pharmacokinetic (PBPK) modeling, bioinformatics, and building visualization tools for effective communication of complex scientific results. He has authored or co-authored more than 20 peer-reviewed publications in toxicology ranging from novel algorithms for interpreting transcriptomics data, to using PBPK modeling for informing chemical safety in juvenile populations.